[Ovarian adenosarcoma with elevated CA125 antigen. Case report and literature review]

Edgar Recinos-Money, Gustavo Escobar-Alfaro, Jorge Contreras, Ernesto Zepeda-Castilla, Carlos Guadalupe Parra-Torres, Carlos Parra-Torres, Paolo di Castro
Cirugia y cirujanos · 2009 · vol. 76(1) , pp. 71–5 · PMID:18492424 · W1520199497
Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This case report describes an ovarian adenosarcoma in a patient with elevated CA125, finding that this antigen may indicate sarcomatous overgrowth and be useful for prognosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Adenosarcomas are rare tumors usually derived from the endometrium. About 50 cases of adenosarcomas of the ovary have been reported. The relationship between adenosarcoma and CA125 has not been described. The authors present a case of adenosarcoma with elevated CA125 because of the unusual presentation of this pathology and also because elevation of the CA125 antigen has not been reported in the literature. CLINICAL CASE: A 42-year-old woman presented for consultation for incidental right ovarian tumor and CA125 of 1100 U/mL. Histology revealed a homologous Müllerian adenosarcoma of the right ovary with sarcomatous overgrowth. CA125 decreased to 16 U/mL after surgery. Sixteen months post-surgery, the patient is disease free and with normal CA125. DISCUSSION: Ovarian adenosarcomas are more aggressive than adenosarcomas of the uterus. Because of the embryological origin, ovarian adenosarcomas are able to produce CA125 antigen, especially in the presence of sarcomatous overgrowth. With these facts, CA125 antigen may be useful as a prognostic factor because it may represent an indirect marker of sarcomatous overgrowth. CONCLUSIONS: CA125 may be useful for follow-up of ovarian adenosarcomas. Elevated CA125 antigen in adenosarcomas of the ovary may be indicative of sarcomatous overgrowth and poor prognosis.

My notes (saved in your browser only)

MeSH descriptors

Adenosarcoma Biomarkers, Tumor CA-125 Antigen Ovarian Neoplasms Adenosarcoma Adenosarcoma Adenosarcoma Adenosarcoma Adenosarcoma Adult Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Biomarkers, Tumor CA-125 Antigen Chemotherapy, Adjuvant Female Humans Hysterectomy Incidental Findings Lymph Node Excision

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (29)

Source provenance

openalex
last seen: 2026-05-10T10:25:40.298144+00:00
pubmed
last seen: 2026-10-08T21:05:28.665087+00:00
License: CC0 · commercial use OK